Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic CancersPablo D. García, Matthew T. Burger, John L. Langowski et al.|Clinical Cancer Research|2014Cited by 111
A Genome-wide CRISPR Screen Identifies ZCCHC14 as a Host Factor Required for Hepatitis B Surface Antigen ProductionAnastasia Hyrina, Meghan Holdorf, Lili Xie et al.|Cell Reports|2019Cited by 74
Supplementary Figures 1 - 5, Tables 1 - 2 from Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic CancersPablo D. García, Matthew T. Burger, John L. Langowski et al.|Unknown|2023Cited by 0
Supplementary Figures 1 - 5, Tables 1 - 2 from Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic CancersPablo D. García, Matthew T. Burger, John L. Langowski et al.|Unknown|2023Cited by 0
Data from Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic CancersPablo D. García, Matthew T. Burger, John L. Langowski et al.|Unknown|2023Cited by 0